Revised EU/Pfizer/BioNTech Covid-19 vaccine deal may lead to a Comirnaty monopoly
The new deal also ensures the EU will have access to the latest versions of future variant-specific updated vaccines once they are authorised for use.
The new deal also ensures the EU will have access to the latest versions of future variant-specific updated vaccines once they are authorised for use.